Health companies launch FDA-approved blockchain pilot

A pilot that aims to study the use of blockchain-enabled data technology to track and verify specialty prescription drugs has been approved by the FDA.

The pilot, which includes a consortium of technology companies, healthcare operators, association groups and more, will focus on intra- and inter-health system medication transport and usage in three states: North Carolina, Indiana and Tennessee. The supply monitoring has the potential to improve quality control of medicine, provide data for more targeted inventory and recall management and even save lives, according to the announcement.

The test implementation of the Drug Supply Chain Security Act will start in August 2019.

The group of companies...